Single User License
INR 200276
Site License
INR 400551
Corporate User License
INR 600827

Service Tax Additional

select a format

Single User License
USD 2995
Site License
USD 5990
Corporate User License
USD 8985


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Opioids Overview to 2021-An Assessment of Pain Management and Dependence

Opioids Overview to 2021-An Assessment of Pain Management and Dependence

  Request for Sample Report

Executive Summary

Opioids Overview to 2021-An Assessment of Pain Management and Dependence GBI Research's latest report, "Opioids Overview to 2021-An Assessment of Pain Management and Dependence" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines the management of opioid dependence in the US, the UK, Germany, Spain, Italy, France, Australia, Japan, India and China. Analysis pertaining to the prescribed opioid users, treatment patterns, and market revenues confirms that the use of weak opioids has fallen dramatically in most markets, while the use of strong opioids has increased. The total market size in the countries covered in this report was $15.7 billion in 2014, of which the US accounted for the highest share, followed by Japan and Germany. The global prevalence of chronic pain was 20-30% in the same year, although most of the prevalence population received inadequate treatment due to the high potential for opioid abuse or misuse. The report also discusses each country's regulatory restrictions, as well as the treatments available for opioid dependence such as withdrawal management, maintenance, and psychosocial support. In addition, it examines dependence treatment settings, trends, and patient referral pathways. Patient access and cost of treatment remain the key barriers to effectively managing opioid dependence in most countries. Scope Dosage and treatment regimes for major opioids used in pain management -Which opioids are used for opioid-na've patients and for patients that experience continuous pain but respond well to opioids? -Which opioids are considered for first-line and second-line treatment? Management of opioid dependence according to WHO treatment guidelines -What are the recommended medications for opioid maintenance, withdrawal, and overdose? -What are the treatment regimes followed when using various pharmacotherapy drugs? -What role does psychosocial treatment play? In-depth country analysis of opioids for pain management, covering pain prevalence, level of opioid use, commonly used opioids, trends, barriers, and rationalization initiatives -What is the overall pain prevalence in each country and is it treated adequately? -To what extent are opioids used to treat pain? -What are the major opioids used and the key associated trends? -Why are patients/prescribers often reluctant to use opioids for pain? -What initiatives have been taken or recommended to facilitate appropriate use of opioids? Regulatory landscape and guidelines for opioid prescription -Which regulatory laws and bodies oversee import, exports, schedules, and controls on opioids in each country? -Which narcotic guidelines discuss the prescribing authorities and licenses required to possess or prescribe controlled drugs? In-depth country analysis of treatment for opioid dependence in all countries, covering dependence, substance abuse trends, treatment usage patterns, and patient referral pathways -How many drug users receive treatment for opioid dependence? -What are the medication usage trends in dependence treatment? -What are the referral pathways for dependent patients? Use of novel formulations to prevent abuse and address unmet need in pain management -How do agonist-antagonist, abuse-resistant, and overdose-reversal formulations aid abuse prevention? Challenges addressing the unmet need in opioid dependence treatment -Which areas need to be improved to address the unmet need in opioid dependence treatment? Reasons To Buy This report will allow you to Identify users of prescribed opioids and associated revenues through 2021, as well as key pain management trends and the most frequently used opioids in the analyzed countries. Determine the drivers and restraints for opioid use in each country, examine patient/prescriber reasons for reluctance to use opioids for pain relief, and the initiatives being taken or recommended to facilitate appropriate use. Gain an understanding of the narcotic guidelines and regulations specific to each country, and determine the prescribing authorities and licenses required to posses/prescribe controlled drugs, the maximum length of time for which an opioid can be prescribed, and recent amendments. Analyze substance abuse and dependence trends, prescribing authorities, treatment usage patterns, and government funding for opioid dependence by examining the percentage of people receiving treatment for opioid misuse, the percentage of dependents receiving treatment, and usage trends associated with medications.

Executive Summary Opioids Overview Classification of Opioids by Potency, Origin and Function Classification and Management of Pain Opioids for Pain Management Effect on Different Organ Systems International Rules for Use of Opioid-Based Analgesics Management of Opioid Dependence WHO Treatment Guidelines for Opioid Dependence-Pharmacological Treatment WHO Treatment Guidelines for Opioid Dependence-Psychosocial Treatment Pharmacotherapy for Opioid Dependence Country Analysis (US, UK, Germany, Spain, Italy, France, Australia, Japan, India, China) Opioids Overview Regulatory Landscape Opioids Market Size Dependence Overview Dependence Treatment and Trends Patient Referral Pathway Unmet Need in Opioid Pain Management Unmet Need in Opioid Dependence Treatment Bibliography

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Opioids, Dependence, pain management, withdrawal treatment, maintenance treatment

Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]